Advanced Search
HE Xuemei, ZHU Jinming. Expression of anti-mullerian hormone and its type Ⅱ receptor in cervical squamous cell carcinoma[J]. Journal of Xuzhou Medical University, 2017, 37(10): 684-688.
Citation: HE Xuemei, ZHU Jinming. Expression of anti-mullerian hormone and its type Ⅱ receptor in cervical squamous cell carcinoma[J]. Journal of Xuzhou Medical University, 2017, 37(10): 684-688.
shu

Expression of anti-mullerian hormone and its type Ⅱ receptor in cervical squamous cell carcinoma

  • 1.

    Graduate School, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China

  • 2.

    Xuzhou Maternity and Child Health Care Hospital, Xuzhou, Jiangsu 221009

More Information
  • Published Date: October 24, 2017
    Graphical Abstract
    • Abstract
  • ObjectiveTo observe the expression and distribution of anti-mullerianhormone (AMH) and its type Ⅱ receptor (AMHR-Ⅱ) in cervical squamous cell carcinoma (CSCC), and discusses the role of AMH and AMHR-Ⅱ in the development of cervical squamous cell carcinoma. MethodsThe expression of AMH and AMHR-Ⅱ were examined by immunohistochemistry and real-time quantitative PCR using 30 CSCC samples, 30 samples of high-grade squamous intraepithelial lesions (HSIL), 30 samples of cervical low-grade squamous intraepithelial lesions (LSIL) and 30 samples of chronic cervicitis (CC) tissues. ResultsCompared with Group CC, Groups CSCC and HSIL showed remarkably decreases in the positive cell number and mRNA level of AMH and AMHR-Ⅱ (P＜0.01). Compared with Group LSIL, Groups CSCC and HSIL showed remarkably decreases in the positive cell number and mRNA level of AMH and AMHR-Ⅱ (P＜0.01). No statistical difference was found as to the positive cell number and mRNA level of AMH and AMHR-Ⅱ between Groups CC and LSIL, and Groups CSCC and HSIL (P>0.05). ConclusionsThe expression of AMH and AMHR-Ⅱ is closely related to the development of cervical squamous cell carcinoma, which are decreased as cervical lesions develop. AMH and AMHR-Ⅱ are expected to be biological indicators for early diagnosis and treatment of cervical squamous cell carcinoma.
    • FullText(HTML)
    • References (18)
  • [1]
    Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012 [J]. CA Cancer J Clin, 2015,65(2):87-108.
    [2]
    Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016,66(2):115-132.
    [3]
    胡蓉,田春花,田进石,等.抗苗勒管激素及其Ⅱ型受体基因多态性在多囊卵巢综合征患者表达的研究[J].实用妇产科杂志,2012,28(9):739-742.
    [4]
    Gracia CR, Sammel MD, Freeman E, et al. Impact of cancer therapies on ovarian reserve [J]. Fertil Steril, 2012,97(1):134-140.
    [5]
    Song JY, Chen KY, Kim SY, et al.The expression of Mullerian inhibiting substance/anti-Mullerian hormone typeⅡreceptor protein and mRNA in benign,borderlineand malignant ovarian neoplasia [J].Int J Oncol, 2009,34(6):1583-1591.
    [6]
    Song JY, Jo HH, Kim MR, et al. Expression of Mullerian inhibiting substance type Ⅱ receptor and antiproliferative effects of MIS on human cervical cancer [J]. Int J Oncol, 2012,40(6):2013-2021.
    [7]
    Panidis D, Georgopoulos NA, Piouka A,et al.The impact of oral contraceptives and metformin on anti-Mullerian hormone serum levels in women with polycystic ovary syndrome [J].Gynecol Endocrinol, 2011,27(8):587-592.
    [8]
    Litta P, D′Agostinoc C, Conte L, et al.Anti-Mullerian hormone trend after laparoscopic surgery in women with ovarian endometrioma [J].Gynecol Endocrinol,2013,29(5):452-454.
    [9]
    Hansen KR, Hodnett GM, Knowlton N, et al. Correlation of ovarian reserve tests with histologically determined primordial follicle number[J]. Fertil Steril, 2011,95(1):170-175.
    [10]
    Anttonen M, Frkkil A, Tauriala H, et al. Anti-Müllerian hormone inhibits growth of AMH type Ⅱ receptor-positivehuman ovarian granulosa cell tumor cells by activating apoptosis[J]. Lab Invest, 2011, 91(11):1605-1614.
    [11]
    Chang HL, Pieretti-Vanmarcke R, Nicolaou F, et al. Müllerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines [J].Gynecol Oncol, 2011,120(1):128-134.
    [12]
    Anttonen M, Farkkila A, Tauriala H, et al. Anti-Müllerian hormone inhibits growth of AMH type Ⅱ receptor-positive human ovarian granulosa cell tumor cells by activating apoptosis [J].Lab Invest, 2011,91(11):1605 -1614.
    [13]
    Yan B, Shi X, Zhang H, et al. Association of serum irisin with metabolic syndrome in obese Chinese adults [J/OL]. PLoS One, 2014,9(4):e94235. doi: 10.1371/journal.pone.0094235.
    [14]
    Wang J, Dicken C, Lustbadee JW, et al. Evidence for a Mullerian inhibiting substance autocrine/paracrine system in adult human endometrium [J].Fertil Steril, 2009,91(4):1195-1203.
    [15]
    刘田雨,姚书忠.宫颈癌肿瘤微环境研究进展[J].国际妇产科学杂志,2015,42(2):149-153.
    [16]
    Deligeoroglou E, Giannouli A, Athanasopoulos N, et al.HPV infection: immunological aspects and their utility in future therapy [J/OL]. Infect Dis Obstet Gynecol, 2013:540850.doi: 10.1155/2013/540850.
    [17]
    Masiakos PT, MacLaughlin DT, Maheswaran S, et al．Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type Ⅱ receptor,bind,and are responsive to MIS [J].Clin Cancer Res, 1999，5(11):3488-3499.
    [18]
    Queiroz C, Silva TC, Alves VA, et al. P16(INK4A) expression as a potential prognostic maker in cervical pre-neoplastic and neoplastic lesions [J]. Pathol Res Pract, 2006,202(2):77-83.
    • Related Articles

Catalog

    Get Citation
    PDF
    XML
    Article views (1319) PDF downloads (108) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References

    Website Copyright © Editorial Office of Journal of Xuzhou Medical University 苏ICP备10010028号

    Email：xzhmuxb@xzhmu.edu.cn

    Address：No. 84, Huaihai West Road, Xuzhou City

    Tel：15380140709（1.13-2.20寒假期间请拨打手机）　0516-85748483

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return